The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
NCT06564363 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 148
Last updated 2024-08-21
Summary
The clinical trial was designed to determine the efficacy (sensitivity and specificity) of the IUrisure test compared to the gold standard cystoscopy and pathology in patients under monitoring for recurrence of urothelial carcinoma.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
IUrisure test
Postoperative patients are followed up every three months on average, and IUrisure test was performed at each follow-up visit.
Sponsors & Collaborators
-
Wuhan Ammunition Life-tech Co., Ltd
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2025-09-30
- Completion
- 2025-12-31
Countries
- China
Study Locations
More Related Trials
-
AI Detection of Bladder Tumors Under Endoscopy
NCT06474338 ·Status: RECRUITING
-
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
NCT06732531 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
NCT06287541 ·Status: RECRUITING ·Phase: NA
-
Genomic Imprinting Testing for Diagnosis of Bladder Cancer
NCT03563443 ·Status: UNKNOWN
-
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
NCT02647112 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study
NCT04194112 ·Status: COMPLETED ·Phase: NA
-
Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits
NCT06193941 ·Status: COMPLETED
-
Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
NCT00052637 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer
NCT06632964 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients
NCT04155359 ·Status: ACTIVE_NOT_RECRUITING
-
Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma
NCT05979909 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment
NCT06766266 ·Status: RECRUITING ·Phase: PHASE1
-
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301 ·Status: COMPLETED
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients
NCT02740426 ·Status: UNKNOWN ·Phase: PHASE2
-
The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors
NCT06490211 ·Status: RECRUITING
-
Efficacy and Safety of UGN-101 in Recurrent Patients
NCT04006691 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
NCT06331299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
NCT03266900 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
NCT05982561 ·Status: RECRUITING
-
Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients
NCT06427291 ·Status: RECRUITING ·Phase: PHASE1
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients
NCT02923557 ·Status: UNKNOWN ·Phase: PHASE2
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
NCT02547350 ·Status: UNKNOWN ·Phase: PHASE2
-
Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
NCT07029256 ·Status: RECRUITING
-
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
NCT05337189 ·Status: RECRUITING
-
Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma
NCT06663735 ·Status: NOT_YET_RECRUITING